Ljubimova Lab

I am the director of the Nanomedicine Research Center for drug delivery and nanomedicine in the Department of Neurosurgery at Cedars-Sinai. My main interests are in differential cancer genomic and proteomic signatures as a tool for finding novel, early markers of cancer growth, and in development and design of new nanomedicine drugs against these and other tumor targets."

Julia Ljubimova, MD, PhD

The Ljubimova Laboratory is working to create a new generation of nanomedicine imaging agents and nanodrugs to bring them to clinical practice. The nanodrugs are biodegradable and nontoxic for patients and deliver multiple antitumor inhibitors, at the same time, directly to cancer cells, overcoming drug resistance and improving treatment efficacy and the quality of cancer patients' lives.


  • Claus-Michael Lehr, PhD
    Professor, Head, Department of Drug Delivery (DDEL) of the 
    Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
    Saarland University
  • Manuel Penichet, MD, PhD
    Professor, Surgery
    Microbiology, Immunology and Molecular Genetics
    Member, Clinical and Translational Science Institute
    California NanoSystems Institute
    Jonsson Comprehensive Cancer Center Tumor Immunology Program Area
    Faculty, Molecular Biology Interdepartmental PhD
  • Paula T. Hammond, PhD
    Bayer Professor and Executive Officer
    Department of Chemical Engineering
    Koch Institute for Integrative Cancer Research
    Associate Editor, ACS Nano
    Massachusetts Institute of Technology, Cambridge, Mass.
  • Meng Ellis, PhD
    Professor of Biomedical Engineering
    Chair of the Women in Science and Engineering Program
    Viterbi School of Engineering
    University of Southern California, Los Angeles
  • Carlos Lodero, PhD, and Jose Capello, PhD
    Nova University of Lisbon
    Department of Chemistry
    Faculty of Science and Technology
    Caprica, Portugal
  • Alexander Lyubimov, MD, PhD
    University of Illinois 
    Department of Toxicology
    Diplomate of the American Board of Toxicology Director
Meet Our Team

Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Ljubimova Laboratory, whose dedicated efforts lead to groundbreaking discoveries.


Ding H, Gangalum PR, Galstyan A, Fox I, Patil R, Hubbard P, Murali R, Ljubimova JY, Holler E.

2017, Nanomedicine. 2017 Feb;13(2):631-639. 

Anchordoquy TJ, Barenholz Y, Boraschi D, Chorny M, Decuzzi P, Dobrovolskaia MA, Farhangrazi ZS, Farrell D, Gabizon A, Ghandehari H, Godin B, La-Beck NM, Ljubimova J, et al. 

ACS Nano. 2017 Jan 24;11(1):12-18. 

Ding H, Fox I, Patil R, Galstyan A, Black KL, Ljubimova JY, Holler E.

J Nanomater. 2017;2017. pii: 4238697. 

Contact the Ljubimova Lab

127 S. San Vicente Blvd.
Advanced Health Sciences Pavilion, Eighth Floor
Los Angeles, CA 90048

Helena Kozlova, MBA